239 related articles for article (PubMed ID: 24452409)
1. Operative failure in minimally invasive parathyroidectomy utilizing an intraoperative parathyroid hormone assay.
Lee S; Ryu H; Morris LF; Grubbs EG; Lee JE; Harun N; Feng L; Perrier ND
Ann Surg Oncol; 2014 Jun; 21(6):1878-83. PubMed ID: 24452409
[TBL] [Abstract][Full Text] [Related]
2. Intraoperative parathyroid hormone assay improves outcomes of minimally invasive parathyroidectomy mainly in patients with a presumed solitary parathyroid adenoma and missing concordance of preoperative imaging.
Barczynski M; Konturek A; Cichon S; Hubalewska-Dydejczyk A; Golkowski F; Huszno B
Clin Endocrinol (Oxf); 2007 Jun; 66(6):878-85. PubMed ID: 17437518
[TBL] [Abstract][Full Text] [Related]
3. What Can We Learn from Intraoperative Parathyroid Hormone Levels that Do Not Drop Appropriately?
Wachtel H; Cerullo I; Bartlett EK; Kelz RR; Karakousis GC; Fraker DL
Ann Surg Oncol; 2015; 22(6):1781-8. PubMed ID: 25354574
[TBL] [Abstract][Full Text] [Related]
4. Impact of intraoperative parathyroid hormone monitoring on the management of patients with primary hyperparathyroidism.
Shawky M; Abdel Aziz T; Morley S; Beale T; Bomanji J; Soromani C; Lam F; Philips I; Matias M; Honour J; Smart J; Kurzawinski TR
Clin Endocrinol (Oxf); 2019 Feb; 90(2):277-284. PubMed ID: 30346646
[TBL] [Abstract][Full Text] [Related]
5. Factors in conversion from minimally invasive parathyroidectomy to bilateral parathyroid exploration for primary hyperparathyroidism.
Hughes DT; Miller BS; Park PB; Cohen MS; Doherty GM; Gauger PG
Surgery; 2013 Dec; 154(6):1428-34; discussion 1434-5. PubMed ID: 24008086
[TBL] [Abstract][Full Text] [Related]
6. Use of Intraoperative Parathyroid Hormone in Minimally Invasive Parathyroidectomy for Primary Hyperparathyroidism: A Systematic Review and Meta-analysis.
Quinn AJ; Ryan ÉJ; Garry S; James DL; Boland MR; Young O; Kerin MJ; Lowery AJ
JAMA Otolaryngol Head Neck Surg; 2021 Feb; 147(2):135-143. PubMed ID: 33211086
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of Intraoperative Parathyroid Monitoring (ioPTH) in predicting a multiglandular or malignant parathyroid disease.
Dobrinja C; Santandrea G; Giacca M; Stenner E; Ruscio M; de Manzini N
Int J Surg; 2017 May; 41 Suppl 1():S26-S33. PubMed ID: 28506410
[TBL] [Abstract][Full Text] [Related]
8. Minimally invasive parathyroidectomy without intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism.
Mihai R; Palazzo FF; Gleeson FV; Sadler GP
Br J Surg; 2007 Jan; 94(1):42-7. PubMed ID: 17083106
[TBL] [Abstract][Full Text] [Related]
9. Minimally invasive parathyroidectomy guided by intraoperative parathyroid hormone monitoring (IOPTH) and preoperative imaging versus bilateral neck exploration for primary hyperparathyroidism in adults.
Ahmadieh H; Kreidieh O; Akl EA; El-Hajj Fuleihan G
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD010787. PubMed ID: 33085088
[TBL] [Abstract][Full Text] [Related]
10. Bilateral neck exploration decreases operative time compared to minimally invasive parathyroidectomy in patients with discordant imaging.
Nehs MA; Ruan DT; Gawande AA; Moore FD; Cho NL
World J Surg; 2013 Jul; 37(7):1614-7. PubMed ID: 23519294
[TBL] [Abstract][Full Text] [Related]
11. Utility of intraoperative PTH for primary hyperparathyroidism due to multigland disease.
Cayo AK; Sippel RS; Schaefer S; Chen H
Ann Surg Oncol; 2009 Dec; 16(12):3450-4. PubMed ID: 19760044
[TBL] [Abstract][Full Text] [Related]
12. Focused parathyroidectomy with intraoperative parathyroid hormone monitoring in patients with lithium-associated primary hyperparathyroidism.
Wade TJ; Yen TW; Amin AL; Evans DB; Wilson SD; Wang TS
Surgery; 2013 May; 153(5):718-22. PubMed ID: 23352236
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of different intraoperative iPTH assay criteria in monitoring of minimally invasive parathyroidectomy for primary hyperparathyroidism].
Papier A; Kenig J; Barczyński M
Przegl Lek; 2014; 71(1):14-8. PubMed ID: 24712263
[TBL] [Abstract][Full Text] [Related]
14. Using parathyroid hormone spikes during parathyroidectomy to guide intraoperative decision-making.
Carr AA; Yen TW; Wilson SD; Evans DB; Wang TS
J Surg Res; 2017 Mar; 209():162-167. PubMed ID: 28032553
[TBL] [Abstract][Full Text] [Related]
15. Significance of rebounding parathyroid hormone levels during parathyroidectomy.
Schneider DF; Ojomo KA; Mazeh H; Oltmann SC; Sippel RS; Chen H
J Surg Res; 2013 Sep; 184(1):265-8. PubMed ID: 23669749
[TBL] [Abstract][Full Text] [Related]
16. Minimal benefit to subsequent intraoperative parathyroid hormone testing after all four glands have been identified.
Ahmed K; Alhefdhi A; Schneider DF; Ojomo KA; Sippel RS; Chen H; Mazeh H
Ann Surg Oncol; 2013 Dec; 20(13):4200-4. PubMed ID: 23943032
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid surgical failures with sufficient decline of intraoperative parathyroid hormone levels: unobserved multiple endocrine neoplasia as an explanation.
Westerdahl J; Bergenfelz A
Arch Surg; 2006 Jun; 141(6):589-94. PubMed ID: 16785360
[TBL] [Abstract][Full Text] [Related]
18. Relation of final intraoperative parathyroid hormone level and outcome following parathyroidectomy.
Heller KS; Blumberg SN
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1103-7. PubMed ID: 19917922
[TBL] [Abstract][Full Text] [Related]
19. Use of a sestamibi-only approach to routine minimally invasive parathyroidectomy.
Opoku-Boateng A; Bolton JS; Corsetti R; Brown RE; Oxner C; Fuhrman GM
Am Surg; 2013 Aug; 79(8):797-801. PubMed ID: 23896247
[TBL] [Abstract][Full Text] [Related]
20. Does the intraoperative parathormone monitoring really affect surgical success in primary hyperparathyroidism?
Ozdemir E; Ozden S; Tutuncu T; Daglar G; Yuksek YN
Acta Chir Belg; 2023 Apr; 123(2):118-123. PubMed ID: 34253156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
